Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVA study of double-blind placebo-controlled methylphenidate titration for ADHD
NL-OMON46942Phase 4Active, not recruiting
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: Number of placebo and non-responders detected, ADHD symptoms and 1 more. Started May 2017; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON46942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46942.